(Q54118877)

English

Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

0 references

author name string

Mehta RR

1

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

Hawthorne ME

2

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

Graves JM

3

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

Mehta RG

4

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

34

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

6

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

902-907

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerability of the synthetic retinoid Fenretinide (HPR)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of fenretinide in the mammary gland of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Simple high-performance liquid chromatographic method for the separation of retinoids including N-(4-hydroxyphenyl)-all-trans-retinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(98)00032-X

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9797705

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54118877&oldid=1412789825"